Who owns BridgeBio Pharma, Inc. (BBI)? Elite investor 13F holders
7 tracked elite investors reported holding BridgeBio Pharma, Inc as of 2026-06-30, including Viking Global Investors, D.E. Shaw, Renaissance Technologies LLC, Bridgewater Associates, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or transthyretin-mediated amyloidosis (ATTR-CM); Fosdenopterin, an intravenous formulation of synthetic cyclic…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Viking Global Investors | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 741017831.00 USD | 9949219.000000 | Shares | reduce | Original filing |
| D.E. Shaw | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 270586362.00 USD | 3633007.000000 | Shares | add | Original filing |
| D.E. Shaw | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Principal | exited | Original filing |
| Renaissance Technologies LLC | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 63817890.00 USD | 856846.000000 | Shares | add | Original filing |
| Bridgewater Associates | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 33377691.00 USD | 448143.000000 | Shares | add | Original filing |
| Tudor Investment | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5747622.00 USD | 77170.000000 | Shares | buy | Original filing |
| Polen Capital Management | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 298069.00 USD | 4002.000000 | Shares | reduce | Original filing |
| GAMCO | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 535995.00 USD | 300000.000000 | Principal | hold | Original filing |
| Ancora Advisors / Ancora Holdings | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.